Status
Conditions
About
This pilot study aims to assess the feasibility and safety of using an ILR to identify the incidence of recurrent AF after an episode of newly diagnosed AF. The study further aims to assess the risk of AF recurrence in this low risk population based on left atrial and left atrial appendage anatomic and functional indices in addition to the standardized clinical CHA2DS2-Vasc score.
Full description
There is a significant incidence of recurrent AF following initial diagnosis of AF.
Inclusion of left atrial (LA) and left atrial appendage (LAA) abnormalities together with risk prediction of CVA using CHA2DS2-Vasc score will identify patients at low or high risk for adverse cardiovascular events in patients with manifest and silent AF.
Patients requiring cardioversion have higher risk of recurrent AF in follow up.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
250 participants in 1 patient group
Loading...
Central trial contact
Elizabeth S Haag, RN MPA; Joseph Levine, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal